Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sergey Okovityi"'
Autor:
Veronika Prikhodko, Daria Chernyuk, Yurii Sysoev, Nikita Zernov, Sergey Okovityi, Elena Popugaeva
Publikováno v:
Cells, Vol 9, Iss 11, p 2351 (2020)
Alzheimer’s disease and cerebral ischemia are among the many causative neurodegenerative diseases that lead to disabilities in the middle-aged and elderly population. There are no effective disease-preventing therapies for these pathologies. Recent
Externí odkaz:
https://doaj.org/article/62f24fbcaa0f4850bd18effe26e45b25
Publikováno v:
Basic Gastronenterology.
Background The unsatisfactory results of the diagnosis and treatment of tuberculosis peritonitis as well as the high rate of disability and mortality in this disease require further study of the pathogenesis of its progression, the features of morpho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::610b49a8234645c966565075c11d433a
https://doi.org/10.1136/gutjnl-2021-iddf.21
https://doi.org/10.1136/gutjnl-2021-iddf.21
Autor:
Jana Goerg, Manuela Sommerfeld, Sergey Okovityi, Ulrich Kintscher, Yasemin Seckin, Dilyara Lauer, Dmitry Ivkin, Elena Kaschina, Bettina Greiner, Alexander N. Kulikov
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 11
International Journal of Molecular Sciences, Vol 22, Iss 5437, p 5437 (2021)
Volume 22
Issue 11
International Journal of Molecular Sciences, Vol 22, Iss 5437, p 5437 (2021)
The effects of the selective sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin in low dose on cardiac function were investigated in normoglycemic rats. Cardiac parameters were measured by intracardiac catheterization 30 min after intrave
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0081b941eff3fe5cf23e393997725958
http://europepmc.org/articles/PMC8196699
http://europepmc.org/articles/PMC8196699
Autor:
I.A. Titovich, Yu.I. Sysoev, N.A. Anisimova, Svetlana M. Napalkova, Sergey Okovityi, D.Yu. Ivkin, V.Ts. Bolotova
Publikováno v:
Farmaciya (Pharmacy). 69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dbfba737221eea2d11bf7a799fdc4f6
https://doi.org/10.29296/25419218-2020-02-03
https://doi.org/10.29296/25419218-2020-02-03
Autor:
Elena Kaschina, A. A. Karpov, Sergey Okovityi, M.V. Krasnova, Alexander N. Kulikov, Dmitry Ivkin, Alexey Smirnov
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 393(9)
The study aimed to investigate the effects of the sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin on chronic heart failure (HF) in normoglycemic rats. The effects of empagliflozin were compared with the standard medications for HF, e.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640e328e90e20e5fa2f1283e26a960db
https://pubmed.ncbi.nlm.nih.gov/32377771
https://pubmed.ncbi.nlm.nih.gov/32377771
Autor:
Mikhail Zarayskii, Marina Parastaeva, Sergey Okovityi, Aleksandr Kulikov, Anatoly Kucher, Galina Ivanova, Mokhamad Khasun, Olga Beresneva, Ivan Kayukov
Publikováno v:
Nephrology Dialysis Transplantation. 34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71520c456686bb11d0179be23256e714
https://doi.org/10.1093/ndt/gfz106.fp085
https://doi.org/10.1093/ndt/gfz106.fp085
Autor:
Sergey Okovityi, Aleksandr Kulikov, Mokhamad Khasun, Irina Zubina, Marina Parastaeva, Anatoly Kucher, Ivan Kayukov, Olga Beresneva, Dmitry Ivkin
Publikováno v:
Nephrology Dialysis Transplantation. 32:iii428-iii429
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab80ddd6dd53541345f74fa183792980
https://doi.org/10.1093/ndt/gfx160.mp004
https://doi.org/10.1093/ndt/gfx160.mp004
Autor:
Aleksandr Kulikov, Sergey Okovityi, Mokhamad Khasun, Dmitry Ivkin, A. A. Karpov, Ivan Kayukov, Olga Galkina, Mikhail Zaraiskii, Olga Beresneva, Anatoly Kucher, Marina Parastaeva
Publikováno v:
Nephrology Dialysis Transplantation. 32:iii613-iii614
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b9158fdc9b1031be8b49c0dcb8a0390
https://doi.org/10.1093/ndt/gfx174.mp504
https://doi.org/10.1093/ndt/gfx174.mp504